DucommunDCO
DCO logo
Fair Value
US$190.8
Share price07 Aug
US$197.073.3% overvalued intrinsic discount
Loading
1Y120.53%
7D10.08%

Defense Modernization And Aerospace Recovery Will Reshape Markets

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
16 Sep 24
Updated
07 Aug 26
Views
194
Not Invested

Last Update 07 Aug 26

Fair value Increased 5.41%

DCO: Missile Upside And Aero Recovery Will Balance Defense Budget Pressure

Ducommun's analyst fair value estimate has been updated from $181 to $190.80 as analysts factor in higher profit margin assumptions, a slightly lower future P/E multiple, and ongoing discussion around missile and munitions exposure versus potential budget pressure on legacy defense programs.

Analyst Commentary

Recent Street research on Ducommun gives you a mixed picture that focuses on execution in missiles and munitions, exposure to commercial aerospace, and how much of this is already captured in the valuation.

Bullish Takeaways

  • Bullish analysts point to Ducommun's positioning for a missiles and munitions ramp as a key driver for potential growth, which they see as partly supporting higher fair value estimates.
  • Several bullish analysts have lifted price targets after Q1 results and estimate updates, which they link to stronger than anticipated commercial aerospace performance and ongoing production deliveries at major OEMs.
  • Some bullish research highlights that compressed multiples across aerospace and defense could leave room for share price upside if Ducommun continues to execute against current expectations.
  • Upcoming company events such as investor day and any potential M&A activity are described as possible catalysts that could influence sentiment if Ducommun provides clearer execution milestones.

Bearish Takeaways

  • Bearish analysts argue that near term upside is largely priced in at current levels, so they see a less compelling risk reward based on recent valuation moves.
  • There is concern that budget pressure on Ducommun's legacy defense programs could offset some of the benefit from missiles and munitions exposure, which could weigh on growth if it proves more severe than the market expects.
  • Some research flags ongoing destocking in commercial aerospace as a headwind that could affect near term revenue and margin execution, even though Q1 conditions were better than feared.
  • One downgrade reflects the view that while catalysts exist, the balance between execution risks and current valuation leaves less room for upside surprise compared with earlier stages of the story.

What’s in the News for Ducommun

  • Ducommun plans an Analyst and Investor Day focused on updating shareholders on progress under VISION 2027 and unveiling a new five year plan called VISION 2032. Source, Key Developments.
  • Management reports that Ducommun is actively pursuing acquisition opportunities and has evaluated multiple potential deals over the past 18 months while keeping a disciplined approach on valuation. Source, Key Developments.
  • Ducommun highlights a new US$650 million credit facility that management says lowers the company’s cost of capital and provides additional capacity to support its acquisition plans. Source, Key Developments.
  • Ducommun is reported as being dropped from several Russell value and microcap oriented indexes, including the Russell Microcap Index, the Russell Microcap Value Benchmark Index, the Russell 3000E Value Benchmark, and the Russell 3000E Index. Source, Key Developments.
  • At the same time, Ducommun is reported as being added to multiple Russell growth and small cap benchmarks, including the Russell 2000 Growth Benchmark, Russell 2000 Growth Defensive Index, Russell 2000 Dynamic Index, Russell 2500 Growth Benchmark, Russell 3000 Growth Benchmark, Russell 3000E Growth Benchmark, and the Russell Small Cap Comp Growth Benchmark. Source, Key Developments.

Valuation Changes for Ducommun

  • Fair Value increased from $181.00 to $190.80, indicating a modest upward revision in the analyst fair value estimate for Ducommun.
  • The Discount Rate was adjusted slightly higher from 8.06% to 8.19%, which reflects a small change in the required return used in the valuation model.
  • Revenue Growth was reduced from 8.23% to 7.87%, pointing to somewhat more conservative top line assumptions for Ducommun.
  • Net Profit Margin rose from 12.64% to 13.69%, indicating higher expected profitability levels in the updated model.
  • The Future P/E moved lower from 25.41x to 24.38x, which assumes a slightly reduced valuation multiple on forward earnings.
0 viewsusers have viewed this narrative update

Key Takeaways

  • Expansion in defense and commercial aerospace, driven by rising demand and modernization, positions Ducommun for sustained top-line growth and increased order activity.
  • Strategic focus on higher-margin products, automation, and domestic sourcing is improving margins, cash flow stability, and overall earnings quality.
  • Heavy dependence on volatile aerospace and defense markets, operational execution challenges, and uncertainty in acquisitions threaten Ducommun's revenue growth, margin stability, and diversification efforts.

Catalysts

About Ducommun
    Provides engineering and manufacturing services for products and applications used in the aerospace and defense, industrial, medical, and other industries in the United States.
What are the underlying business or industry changes driving this perspective?
  • Elevated global defense spending and the replenishment of missile and radar inventories-highlighted by strong double-digit growth in both segments and a 30% increase in missile backlog-positions Ducommun to sustain and expand revenue as defense modernization accelerates over the next several years, with increasing program content and order activity.
  • Strengthening demand for commercial aircraft, particularly with increasing Boeing 737 and 787 build rates and projected end to destocking in 2025/2026, underpins a likely recovery and longer-term rebound in top-line growth for Ducommun's commercial aerospace business.
  • Ongoing mix shift toward higher-margin engineered products and aftermarket (maintained at 23% of revenues, moving toward 25%+), together with value-driven pricing and restructuring actions, is increasing gross margins (recorded at 26.6% in Q2), which supports sustained improvements in net margins and earnings.
  • Facility consolidations, automation, and digital initiatives expected to generate $11-13 million in annual savings (with full benefits ramping in late 2025–2026), set the stage for further operating margin expansion and better cash flow conversion (targeting 100% in the coming years).
  • Minimal exposure to tariff impacts, and high percentage of domestic production and sourcing, should allow Ducommun to capitalize on the industry-wide shift toward supply chain localization, potentially capturing increased market share and stabilizing contract flows, thereby reducing earnings volatility and supporting stable free cash flow.
Ducommun Earnings and Revenue Growth

Ducommun Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Ducommun's revenue will grow by 7.9% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -2.5% today to 13.7% in 3 years time.
  • Analysts expect earnings to reach $148.7 million (and earnings per share of $7.98) by about August 2029, up from -$21.2 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 25.4x on those 2029 earnings, up from -140.4x today. This future PE is lower than the current PE for the US Aerospace & Defense industry at 39.0x.
  • Analysts expect the number of shares outstanding to grow by 1.18% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.19%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Ducommun continues to face significant cyclical risk connected to commercial aerospace customers like Boeing and Spirit AeroSystems; persistent destocking and uncertain ramp-up timelines introduce volatility in aerospace revenue, which could negatively impact top-line growth in low-demand cycles.
  • There is a growing concentration of revenue from the defense sector, especially missile and radar programs, exposing the company to shifts in U.S. government defense budgets and platform priorities-potentially impacting both revenue and margin stability if defense spending slows or focus shifts away from Ducommun's key franchises.
  • Execution risks associated with facility consolidation, product line recertification, and transitioning work to new or lower-cost locations (such as the ramp-up at Coxsackie and Guaymas) may lead to unforeseen production delays, temporary operating inefficiencies, or customer disruptions, adversely affecting near
  • and mid-term margins and earnings.
  • Ducommun's ability to scale up its higher-margin engineered product and aftermarket portfolio partly hinges on successful and timely acquisitions; intensifying competition for quality assets or delayed/integrated acquisitions could slow margin expansion and inhibit revenue diversification, limiting the pace of long-term earnings growth.
  • Sustained pressure from unfavorable sales mix (as seen in lower Structural Systems margins) and ongoing restructuring costs, combined with reliance on favorable product mix for margin gains, may challenge the company's ability to consistently expand net margins and achieve targeted profitability if market or execution tailwinds weaken.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $190.8 for Ducommun based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $216.0, and the most bearish reporting a price target of just $150.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.1 billion, earnings will come to $148.7 million, and it would be trading on a PE ratio of 25.4x, assuming you use a discount rate of 8.2%.
  • Given the current share price of $197.07, the analyst price target of $190.8 is 3.3% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Ducommun?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$190.8
vs US$197.073.3% overvalued intrinsic discount
PastFuture-57m1b2015201820212024202620272029Revenue US$1.1bEarnings US$148.7m
7.9%
Revenue growth
13.7%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Ducommun

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Excellent balance sheet and fair value.

Market capUS$3.0b
PB4.3x
Estimated Growth7.8%
Dividend YieldN/A
Full analysis

CEO & management

Stephen Oswald
CEO
8.9yrs
CEO Tenure

Provides engineering and manufacturing services for products and applications used in the aerospace and defense, industrial, medical, and other industries in the United States.